oseen · source-linked reporting

McKinsey & Company agrees to pay $650 million and enter a deferred prosecution agreement with the U.S.

Opioid epidemic in the United States — McKinsey & Company agrees to pay $650 million and enter a deferred prosecution agreement with the U.S. Department of Justice to resolve criminal charges related to its advisory wor

Published December 13, 2024· Updated October 28, 2026·1 min read

Context: Opioid epidemic in the United States.

McKinsey & Company agrees to pay $650 million and enter a deferred prosecution agreement with the U.S. Department of Justice to resolve criminal charges related to its advisory work for Purdue Pharma on increasing OxyContin sales, including conspiracy to misbrand a drug and obstruction of justice. [https://www.aljazeera.com/economy/2024/12/13/mckinsey-to-pay-650m-to-settle-us-opioid-consulting-probe (Al Jazeera)]

Event summary via Wikipedia Current Events (2024-12-13).